Observational studyBMC pulmonary medicine2026
High prevalence of previously undiagnosed COPD in individuals undergoing lung cancer screening in Korea.
Observational study in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic obstructive pulmonary disease (COPD) remains substantially underdiagnosed, particularly in individuals with mild or early-stage disease. Individuals undergoing lung cancer screening represent a high-risk population due to significant smoking exposure; however, the burden of previously undiagnosed COPD in this real-world clinical setting remains insufficiently characterized.
methodsThis retrospective observational study included individuals who underwent national lung cancer screening using low-dose computed tomography (LDCT) at a tertiary referral center between September 2019 and December 2022. The study population consisted of individuals referred for pulmonologist consultation after screening, reflecting real-world clinical practice. Participants without a prior diagnosis of COPD who underwent pulmonary function testing were included. Clinical characteristics, pulmonary function parameters, and CT findings were analyzed. Multivariable logistic regression analysis was performed to identify factors associated with previously undiagnosed COPD.
resultsAmong 279 individuals who underwent pulmonologist consultation, 170 had available spirometry and were included in the analysis. Of these, 63 individuals (37.1%) met spirometric criteria for COPD despite having no prior diagnosis. Participants with previously undiagnosed COPD were more likely to report dyspnea and demonstrated greater physiologic impairment and structural lung abnormalities, including a trend toward lower diffusion capacity and CT-defined emphysema. In multivariable analysis, dyspnea, reduced DLCO, and CT-defined emphysema were independently associated with COPD.
conclusionsA substantial proportion of individuals undergoing lung cancer screening were found to have previously undiagnosed COPD. These findings highlight a gap in real-world screening workflows and support the potential value of integrating spirometry or respiratory assessment into lung cancer screening programs to facilitate early detection and timely management of COPD in high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.